TD Waterhouse Canada’s Bristol-Myers Squibb BMY Stock Holding History

TD Waterhouse Canada’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Buy	27,645 +14,095	+104%	+$822K	0.01%	591
2025 Q4	$731K	Sell	13,550 -1,539	-10%	-$74K	﹤0.01%	626
2025 Q3	$716K	Sell	15,089 -214,772	-93%	-$10M	﹤0.01%	621
2025 Q2	$10.9M	Sell	229,861 -39,277	-15%	-$1.93M	0.08%	183
2025 Q1	$16M	Sell	269,138 -1,175	-0.4%	-$68.5K	0.13%	137
2024 Q4	$15.3M	Buy	270,313 +16,293	+6%	+$910K	0.12%	145
2024 Q3	$13.4M	Buy	254,020 +136,877	+117%	+$6.42M	0.11%	157
2024 Q2	$4.84M	Sell	117,143 -154,499	-57%	-$6.91M	0.04%	246
2024 Q1	$15M	Sell	271,642 -14,788	-5%	-$753K	0.11%	151
2023 Q4	$16.2M	Sell	286,430 -95,438	-25%	-$5.01M	0.15%	116
2023 Q3	$23.1M	Sell	381,868 -20,890	-5%	-$1.28M	0.24%	79
2023 Q2	$27.1M	Buy	402,758 +213,282	+113%	+$14.3M	0.27%	71
2023 Q1	$14.3M	Sell	189,476 -5,673	-3%	-$400K	0.15%	112
2022 Q4	$15.4M	Buy	195,149 +867	+0.4%	+$65.4K	0.17%	98
2022 Q3	$14.9M	Buy	194,282 +31,125	+19%	+$2.26M	0.17%	97
2022 Q2	$13.5M	Sell	163,157 -3,692	-2%	-$281K	0.15%	99
2022 Q1	$13.1M	Buy	166,849 +2,247	+1%	+$151K	0.13%	111
2021 Q4	$10.9M	Buy	+164,602	New	+$9.66M	0.11%	133

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Waterhouse Canada's BMY Position: Q1 2026 in Review

TD Waterhouse Canada increased its Bristol-Myers Squibb (BMY) stake by 104% in Q1 2026, buying an estimated $822K and bringing the position to 27,645 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #591.

TD Waterhouse Canada first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $27.1M in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

TD Waterhouse Canada held 27,645 shares of Bristol-Myers Squibb worth $1.71M as of Q1 2026.
TD Waterhouse Canada bought 14,095 Bristol-Myers Squibb shares in Q1 2026, an estimated $822K.
Bristol-Myers Squibb made up 0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #591 holding.
TD Waterhouse Canada first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Bristol-Myers Squibb position peaked at $27.1M in Q2 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.